乳腺癌内分泌治疗研究进展(5)
[14] Ingle JN, Tu D, Pater JL, et al. Intent—to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer；NCIC CTG MA 17[J]. Ann Oncol, 2008, 19(5)：877-882.
[15] Mamounas EP, Jeong JH, Wickerham DL, et al. Benefit from exemestane aft extended adjuvant therapy after 5 years of adjuvant tamoxifen}intention-to-treat analysis of the national surgical adjuvant breast and bowel project B-33 trial[J]. J Clin Onc, 2008, 26(12):1965-1971.
[16] Paul E, Goss MD, James N Ingle, et al. Exemestane for Breast-Cancer Prevention in Postmenopausal Women[J]. The N Engl Med, 2011, 364(25):2381-2391.
[17] Demicheli R, Terenziani M, Valagussa P, et al. Local recurrences following mastectomy：support for the concept of tumor dormancy[J]. J Natl Cancer lnst, 1994, 86(1)：45-48.
[18] Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy lumpectomy，and lumpectomy plus irradiation for the treatment of invasive breast cancer[J]. N Engl J Med, 2002, 347(16):1233-1241.
[19] Yin W, Di G, Zhou L, et al. Time-varying pattern of recurrence risk for Chinese breast cancer patients[J]. Breast Cancer Res Treat, 2009,14(3): 527-535.
[20] 中国抗癌协会乳腺癌专业委员会. 中国绝经前女性乳腺癌患者辅助治疗后绝经判断标准及芳香化酶临床应用共识(草案修正案)[J]. 中国癌症杂志, 2011, 21(5)：473-475.
(收稿日期：2012-05-24)
, 百拇医药(朱悦茗 李丹 吴学勇)
[15] Mamounas EP, Jeong JH, Wickerham DL, et al. Benefit from exemestane aft extended adjuvant therapy after 5 years of adjuvant tamoxifen}intention-to-treat analysis of the national surgical adjuvant breast and bowel project B-33 trial[J]. J Clin Onc, 2008, 26(12):1965-1971.
[16] Paul E, Goss MD, James N Ingle, et al. Exemestane for Breast-Cancer Prevention in Postmenopausal Women[J]. The N Engl Med, 2011, 364(25):2381-2391.
[17] Demicheli R, Terenziani M, Valagussa P, et al. Local recurrences following mastectomy：support for the concept of tumor dormancy[J]. J Natl Cancer lnst, 1994, 86(1)：45-48.
[18] Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy lumpectomy，and lumpectomy plus irradiation for the treatment of invasive breast cancer[J]. N Engl J Med, 2002, 347(16):1233-1241.
[19] Yin W, Di G, Zhou L, et al. Time-varying pattern of recurrence risk for Chinese breast cancer patients[J]. Breast Cancer Res Treat, 2009,14(3): 527-535.
[20] 中国抗癌协会乳腺癌专业委员会. 中国绝经前女性乳腺癌患者辅助治疗后绝经判断标准及芳香化酶临床应用共识(草案修正案)[J]. 中国癌症杂志, 2011, 21(5)：473-475.
(收稿日期：2012-05-24)
, 百拇医药(朱悦茗 李丹 吴学勇)